Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma
2012 · Hepatology · 281 citations
https://doi.org/10.1002/hep.26168
E
Eishiro Mizukoshi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
265
Papers
8.9K
Citations
48
h-index
132
i10-index
Eishiro Mizukoshi is an academic researcher from Kanazawa University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 48, co-authored 226 publications.
ORCID: 0000-0002-2036-9599Papers by this author
worksComparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
2011 · Hepatology · 175 citations
https://doi.org/10.1002/hep.24149
Immune cell therapy for hepatocellular carcinoma
2019 · Journal of Hematology & Oncology · 131 citations
https://doi.org/10.1186/s13045-019-0742-5
Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis
2020 · Journal for ImmunoTherapy of Cancer · 106 citations
https://doi.org/10.1136/jitc-2020-001367
Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
2015 · Hepatology Research · 81 citations
https://doi.org/10.1111/hepr.12601
Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis
2021 · Nature Cancer · 67 citations
https://doi.org/10.1038/s43018-021-00251-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat